Patient Survey Reveals Significant Physical Burden of Psoriatic Disease
Researchers sought to assess patients’ understanding of the systemic nature of psoriatic disease.
Psoriasis Information Center
Psoriasis Progression to Inflammatory Arthritis Reduced With Biologics
Researchers evaluated the association between biological therapy and the time to incident inflammatory psoriatic arthritis.
Machine Learning Accurately Predicts Biologic Discontinuation in Psoriasis
Researchers assessed the accuracy of a traditional statistical risk factor-based model versus machine learning in predicting the 5-year probability of biologic discontinuation.
Biologics May Reduce Psoriatic Arthritis Development in Patients With Psoriasis
Researchers assessed whether biologics reduce the incidence of psoriatic arthritis among patients with psoriasis.
Targeted Therapies Do Not Increase Cardiovascular Risk in Psoriasis
Researchers sought to investigate the effect of targeted therapies on cardiovascular risk in psoriasis and psoriatic arthritis.
Psoriasis Tied to Elevated Risk for Celiac Disease
People with psoriasis have double the odds of celiac disease vs people without psoriasis.
Serious Infections Rare With Immunomodulating Agents for Pediatric Psoriasis
Study investigators assessed the risk of infection among pediatric patients undergoing treatment with methotrexate, etanercept, or ustekinumab for psoriasis.
Cigarette Smoking Identified as Risk Factor for Postmenopausal Psoriasis
A team of investigators sought to determine whether alcohol consumption or cigarette smoking contributed to the risk of developing psoriasis among postmenopausal women.
Patient Preference for Psoriasis Biologic Treatment Changed Following the COVID-19 Pandemic
Investigators sought to determine what effect the COVID-19 pandemic had on patient preference for biologic treatment for psoriasis.
Psoriatic Arthritis Linked to Comorbidity Burden, Ustekinumab Persistence in Psoriasis
The researchers sought to evaluate whether there was an association between the presence of psoriasis and concomitant psoriatic arthritis and comorbidity burden and treatment outcomes.
Brodalumab Promising for the Treatment of Plaque Psoriasis in a Real-World Setting
The effectiveness and safety profile of brodalumab during a period of 104 weeks in everyday practice are reported.
Systemic Agent Initiation for Psoriasis Is Highest in Spring
Does systemic agent prescribing for psoriasis vary by season or other exacerbating factors?
Anxiety and Depression Association in Patients With Pediatric Psoriasis
Investigators sought to elucidate the prevalence of anxiety and depression in patients with pediatric psoriasis and advocate for psychological screening and intervention as needed.
In Psoriatic Arthritis, Screening for Comorbidities Guides Treatment Selection
A GRAPPA working group highlighted the importance of screening for comorbidities to guide treatment selection among patients with psoriatic arthritis.
Adalimumab Plus Methotrexate Promising for Chronic Plaque Psoriasis
The efficacy, safety, pharmacokinetics, and immunogenicity of adalimumab combined with MTX compared with that adalimumab in patients with chronic plaque psoriasis is evaluated.
COVID-19-Related New-Onset and Exacerbated Skin Diseases
Investigators sought to evaluate the association between COVID-19 infection and persistent or new-onset rash following infection.
Updated Psoriatic Arthritis Treatment Recommendations Released
Updated GRAPPA psoriatic arthritis treatment recommendations now include the use of biosimilars and the tapering of therapy.
Methotrexate Access for Autoimmune Diseases in the Post-Roe Setting
AMA president Jack Resneck, Jr., MD, and dermatologist David M. Pariser, MD, FAAD, tell us their thoughts and experiences on the challenges patients face in accessing methotrexate for psoriasis and other autoimmune diseases.
Risankizumab Improves Health-Related Quality of Life in Psoriatic Arthritis
Researchers sought to evaluate the impact of risankizumab vs placebo on health care-related quality of life and other patient-reported outcomes in patients with psoriatic arthritis.
Use of Recommendations for Managing Psoriasis During Pregnancy Varies
A survey reveals the extent of implementation of recommendations for the treatment of psoriasis in patients of reproductive age.
- Loading...
Loading...
Want to read more?
Please login or register first to view this content.
Next post in Psoriasis Information Center
Loading... 
Loading...